Management of TIPS-related refractory hepatic encephalopathy with reduced Wallgraft endoprostheses

Journal of Vascular and Interventional Radiology

Volumn 14, Issue 3, 2003, Pages 369-374

  Madoff, David C ^a   Perez Young, Irene V ^a   Wallace, Michael J ^a   Skolkin, Mark D ^b   Toombs, Barry D ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

Encephalopathy, hepatic; Shunts, portosystemic

Indexed keywords

ADULT; AGED; ALLOGRAFT; ARTICLE; ASCITES; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOPROSTHESIS; EVALUATION; FEASIBILITY STUDY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; MALE; NONHUMAN; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; REDUCTION; TRANSPLANTATION;

EID: 0037335490     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000058418.01661.48     Document Type: Article

References (16)

1. Zuckerman DA, Darcy MD, Bocchini TP, Hildebolt CF. Encephalopathy after transjugular intrahepatic portosystemic shunting: analysis of incidence and potential risk factors. AJR Am J Roentgenol 1997; 169:1727-1731.
2. Forauer AR, McLean GK. Transjugular intrahepatic portosystemic shunt constraining stent for the treatment of refractory postprocedural encephalopathy: a simple design utilizing a Palmaz stent and Wallstent. J Vasc Interv Radiol 1998; 9:443-446.
3. Paz-Fumagalli, R, Crain MR, Mewissen MW, Varma RR. Fatal hemodynamic consequences of therapeutic closure of a transjugular intrahepatic portosystemic shunt. J Vasc Interv Radiol 1994; 5:831-834.
4. Haskal ZJ, Cope C, Soulen MC, Shlansky-Goldberg RD, Baum R, Redd DCB. Intentional reversible thrombosis of transjugular intrahepatic portosystemic shunts. Radiology 1995; 195:485-488.
5. Kerlan RK Jr, LaBerge JM, Baker EL. Successful reversal of hepatic encephalopathy with intentional occlusion of transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 1995; 6:917-921.
6. Haskal ZJ, Middlebrook MR. Creation of stenotic stent to reduce flow through a transjugular intrahepatic portosystemic shunt. J Vasc Interv Radiol 1994; 5:827-830.
7. Hauenstein KH, Haag K, Ochs A, Langer M, Rossi M. The reducing stent: treatment for transjugular intrahepatic portosystemic shunt-induced refractory hepatic encephalopathy and liver failure. Radiology 1995; 194:175-179.
8. Gerbes AL, Waggershauser T, Holl J, Gulberg A, Fischer G, Reiser M. Experiences with novel techniques for reduction of stent flow in transjugular intrahepatic portosystemic shunts. Z Gastroenterol 1998; 36:373-377.
9. Conn HO, Leevy CM, Vlahcevic, et al. Comparison of lactulose and neomycin in the treatment of chronic-portal systemic encephalopathy. Gastroenterology 1977; 72:573-583.
10. Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP, Luketic VA, Cheatham AK. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994; 20:46-55.
11. Cordoba J, Blei AT. Treatment of hepatic encephalopathy. Am J Gastroenterol 1997; 92:1429-1439.
12. Pomier-Layrargues G. TIPS and hepatic encephalopathy. Sem Liver Disease; 16: 315-320.
13. Jalan R, Hayes PC. Risk of intentional reversible thrombosis of transjugular intrahepatic portosystemic shunt. Radiology 1995; 197:587.
14. Haskal ZJ, Brennecke LH. Transjugular intrahepatic portosystemic shunts formed with polyethylene terephthalate-covered stents: experimental evaluation in pigs. Radiology 1999; 213:853-859.
15. Otal P, Rousseau H, Vinel J-P, Ducoin H, Hassissene S, Joffre F. High occlusion rate in experimental transjugular intrahepatic portosystemic shunt created with a Dacron-covered nitinol stent. J Vasc Interv Radiol 1999; 10:183-188.
16. Quaretti P, Michieletti E, Rossi S. Successful treatment of TIPS-induced hepatic failure with an hourglass stent-graft: a simple new technique for reducing shunt flow. J Vasc Interv Radiol 2001; 12:887-890.